UroGen Pharma Ltd.
NASDAQ:URGNBiotechnology
Healthcare
$29.79 -1.22%
-$0.40 today
- Market cap
- $1.46B
- Beta
- 1.62
- P/E (TTM)
- -12.2
- EPS (TTM)
- -$2.65
52W Low $12.73High $33.79
Volume 1.14M
Average 0.79M
Price history
UroGen Pharma Ltd. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
+17.89%
Period high
$50.29
Period low
$17.00
Latest
$29.79
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| SC 13G/A | Nov 13, 2026 | Nov 13, 2026 | |
| 10-Q | Nov 4, 2026 | Nov 4, 2026 | |
| 8-K | Nov 4, 2026 | Nov 4, 2026 | |
| S-8 | Nov 4, 2026 | Nov 4, 2026 | |
| SC 13G/A | Oct 27, 2026 | Oct 27, 2026 | |
| 4 | Oct 9, 2026 | Oct 9, 2026 | |
| 4 | Sep 9, 2026 | Sep 9, 2026 | |
| 4 | Sep 9, 2026 | Sep 9, 2026 | |
| 4 | Aug 28, 2026 | Aug 28, 2026 | |
| 4 | Aug 24, 2026 | Aug 24, 2026 | |
| 8-K | Aug 20, 2026 | Aug 20, 2026 | |
| SC 13G/A | Aug 12, 2026 | Aug 12, 2026 | |
| 8-K | Aug 5, 2026 | Aug 5, 2026 | |
| 10-Q | Aug 5, 2026 | Aug 5, 2026 | |
| 4 | Jul 10, 2026 | Jul 10, 2026 |
Competitors
Who does UroGen Pharma Ltd. compete with?
Open similar companies to compare their filings and price history.
Competitors
Peer companies in the same sector
Questions
Filing questions
Common questions about URGN's filings, answered from its disclosures.
What is the latest URGN filing?
The latest filing shown is SC 13G/A dated Nov 13, 2026.
How many recent filings does URGN have?
Intrinsic Alpha currently shows 20 recent filings for URGN.
Continue the stock analysis
Jump to another research area for this company.